Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 5/20 | 0.32 |
| ▸ | PPARA | Q07869 | 5/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 3/20 | 0.32 |
| ▸ | HTR7 | P34969 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26485213 | 0.80 | PARP14 (0.41) | ALOX5MAPT | |
| SCHEMBL24433660 | 0.80 | CDC14B (0.36) | CYP2C19 | |
| SCHEMBL24433581 | 0.79 | ALOX5 (0.40) | ALOX5PTPN1AKR1C3AKR1C2NPC1 | |
| SCHEMBL26194141 | 0.78 | CYP2A6 (0.39) | ALOX5PTPN1AKR1C3AKR1C2NPC1 | |
| SCHEMBL2991264 | 0.76 | KIF11 (0.43) | PTPN1KIF11PPARGPPARACYP2C9 | |
| SCHEMBL26194139 | 0.74 | NPC1 (0.44) | ALOX5PTPN1AKR1C3AKR1C2NPC1 | |
| SCHEMBL24433582 | 0.74 | HSP90AA1 (0.43) | ALOX5NPC1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL26194140 | 0.72 | MAOA (0.41) | ALOX5PTPN1AKR1C3AKR1C2MAPT | |
| SCHEMBL15853162 | 0.72 | HSD11B1 (0.41) | PTPN1AKR1C3AKR1C2KIF11PPARG | |
| SCHEMBL17500087 | 0.70 | CA2 (0.55) | KIF11PPARGPPARACYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230284516-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230284516-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230140064-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230140064-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-04 | — | — | US | disclosed |
| US-20220153769-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230284516-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, LBR, C1R | ALOX5 1710/4885PTPN1 3922/4885AKR1C3 397/4885 |
| US-20230140064-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, CCND3 | ALOX5 784/4885PTPN1 4652/4885AKR1C3 543/4885 |
| US-20220153769-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ODC1, OCIAD1, OCIAD2 | ALOX5 428/4885PTPN1 4819/4885AKR1C3 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.